Natural Health Trends Reports Fourth Quarter and Full Year 2023 Financial Results

– Fourth quarter revenue of $10.9 million increased 3% compared to the third quarter of 2023 
– Cash flows from operations improved $2.0 million year-over-year before tax installment payments
– Declared a quarterly cash dividend of $0.20 per share 

HONG KONG, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the fourth quarter and full year ended December 31, 2023.

Fourth Quarter 2023 Financial Highlights

•		Revenue of $10.9 million increased 3% compared to $10.6 million in the third quarter of 2023 and decreased 13% compared to $12.5 million in the fourth quarter of 2022.
•		Operating loss was $242,000 compared to operating loss of $292,000 in the third quarter of 2023 and operating income of $43,000 in the fourth quarter of 2022.
•		Net income was $358,000, or $0.03 per diluted share, compared to $172,000, or $0.02 per diluted share, in the third quarter of 2023 and $188,000, or $0.02 per diluted share, in the fourth quarter of 2022.
•		The number of Active Members1 were down 6% to 32,410 at December 31, 2023, compared to 34,660 at September 30, 2023, and decreased 16% compared to 38,660 at December 31, 2022.
1 Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve-month period.

Full Year 2023 Financial Highlights

•		Revenue of $43.9 million decreased 11% compared to $49.1 million in 2022.
•		Operating loss was $1.7 million, compared to $270,000 in 2022.
•		Net income was $568,000, or $0.05 per diluted share, compared to $313,000, or $0.03 per diluted share, in 2022.

Management Commentary

“We managed to achieve a sequential increase in orders despite tepid consumer sentiment in China and price increases in several markets in the quarter. We believe the increased frequency and size of in-person activities contributed to the uptick. We plan to sponsor more such events in the coming months to continue improving the effectiveness of our market campaigns,” commented Chris Sharng, President of Natural Health Trends Corp.

Mr. Sharng continued, “Though under pressure from lingering inflation and stronger dollar, we succeeded in protecting margin and controlling costs. With more emphasis on training in the coming year, we believe we are well positioned to benefit from further volume boost.”

Balance Sheet and Cash Flow

•		Net cash used in operating activities was $69,000 in the fourth quarter of 2023, compared net cash provided by operating activities of $938,000 in the fourth quarter of 2022. Net cash used in operating activities was $4.3 million in 2023, compared to $4.9 million in 2022. Before tax installment payments, the liability of which arises from the 2017 U.S. Tax Cuts and Jobs Act (the “Act Act”), cash used in operating activities was $1.2 million in 2023, versus $3.2 million a year ago. Of the total Tax Act liability of $20.2 million, $11.2 million has been paid to date.
•		Total cash and cash equivalents were $56.2 million as of December 31, 2023, down from $69.7 million as of December 31, 2022.
•		On February 5, 2024, the Company’s Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on March 1, 2024 to stockholders of record as of February 20, 2024.

The Company expects to issue its 2023 audited financial results in late February with its Annual Report on Form 10-K to be filed with the United States Securities and Exchange Commission. These financial results are preliminary and the accompanying financial statements have not been audited or have not yet been reviewed by the Company’s independent accountants. Significant updates and revisions may be required before the release of the Company’s 2023 audited financial results.

Fourth Quarter and Full Year 2023 Financial Results Conference Call

Management will host a conference call to discuss the fourth quarter and full year 2023 financial results today, Wednesday, February 7, 2024 at 11:30 a.m. Eastern Time. The conference call details are as follows:

Date:	Wednesday, February 7, 2024
Time:	11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time
Dial-in:	1-877-407-0789 (Domestic) 1-201-689-8562 (International)
Conference ID:	13743993
Webcast:	https://viavid.webcasts.com/starthere.jsp?ei=1653011&tp_key=5a8602f7ee

For those unable to participate during the live broadcast, a replay of the call will also be available from 2:30 p.m. Eastern Time on February 7, 2024 through 11:59 p.m. Eastern Time on February 14, 2024 by dialing 1-844-512-2921 (domestic) and 1-412-317-6671 (international) and referencing the replay pin number:  13743993.

About Natural Health Trends Corp.

Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company’s website at www.naturalhealthtrendscorp.com.

Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Such forward-looking statements are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption “Risk Factors” in Natural Health Trends Corp.’s Annual Report on Form 10-K filed on March 3, 2023 with the Securities and Exchange Commission (SEC), as well as in subsequent reports filed this year with the SEC. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.

NATURAL HEALTH TRENDS CORP. CONSOLIDATED BALANCE SHEETS (In thousands, except share data)
		December 31,
		2023				2022
		(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents		$	56,178			$	69,667
Inventories			4,293				4,525
Other current assets			3,758				3,359
Total current assets			64,229				77,551
Property and equipment, net			266				394
Operating lease right-of-use assets			3,319				3,992
Restricted cash			39				79
Deferred tax asset			369				195
Other assets			869				606
Total assets		$	69,091			$	82,817
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable		$	990			$	810
Income taxes payable			3,716				2,972
Accrued commissions			2,067				2,943
Other accrued expenses			1,170				1,181
Deferred revenue			6,166				5,597
Amounts held in eWallets			3,945				4,895
Operating lease liabilities			1,146				1,135
Other current liabilities			784				905
Total current liabilities			19,984				20,438
Income taxes payable			5,054				9,098
Deferred tax liability			135				141
Operating lease liabilities			2,318				2,989
Total liabilities			27,491				32,666
Stockholders’ equity:
Preferred stock			—				—
Common stock			13				13
Additional paid-in capital			84,695				86,102
Accumulated deficit			(17,703	)			(9,056	)
Accumulated other comprehensive loss			(1,069	)			(1,004	)
Treasury stock, at cost			(24,336	)			(25,904	)
Total stockholders’ equity			41,600				50,151
Total liabilities and stockholders’ equity		$	69,091			$	82,817

NATURAL HEALTH TRENDS CORP.  CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data)
		Three Months Ended December 31,								Year Ended December 31,
		2023				2022				2023				2022
		(Unaudited)								(Unaudited)
Net sales		$	10,937			$	12,512			$	43,924			$	49,134
Cost of sales			2,789				3,263				11,175				12,661
Gross profit			8,148				9,249				32,749				36,473
Operating expenses:
Commissions expense			4,553				5,377				18,414				20,747
Selling, general and administrative expenses			3,837				3,829				16,006				15,996
Total operating expenses			8,390				9,206				34,420				36,743
Income (loss) from operations			(242	)			43				(1,671	)			(270	)
Other income, net			708				400				2,416				872
Income before income taxes			466				443				745				602
Income tax provision			108				255				177				289
Net income		$	358			$	188			$	568			$	313
Net income per common share:
Basic		$	0.03			$	0.02			$	0.05			$	0.03
Diluted		$	0.03			$	0.02			$	0.05			$	0.03
Weighted-average number of common shares outstanding:
Basic			11,448				11,423				11,436				11,362
Diluted			11,461				11,423				11,456				11,423

NATURAL HEALTH TRENDS CORP. CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands)
		Year Ended December 31,
		2023				2022
CASH FLOWS FROM OPERATING ACTIVITIES:			(Unaudited)
Net income		$	568			$	313
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization			164				204
Share-based compensation			161				—
Noncash lease expense			1,109				1,172
Deferred income taxes			(178	)			90
Changes in assets and liabilities:
Inventories			228				680
Other current assets			(452	)			992
Other assets			(270	)			(67	)
Accounts payable			181				52
Income taxes payable			(3,299	)			(1,404	)
Accrued commissions			(866	)			(654	)
Other accrued expenses			(4	)			(732	)
Deferred revenue			565				(2,901	)
Amounts held in eWallets			(947	)			(1,432	)
Operating lease liabilities			(1,119	)			(1,220	)
Other current liabilities			(119	)			55
Net cash used in operating activities			(4,278	)			(4,852	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment			(46	)			(143	)
Net cash used in investing activities			(46	)			(143	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Dividends paid			(9,215	)			(9,138	)
Net cash used in financing activities			(9,215	)			(9,138	)
Effect of exchange rates on cash, cash equivalents and restricted cash			10				(486	)
Net decrease in cash, cash equivalents and restricted cash			(13,529	)			(14,619	)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period			69,746				84,365
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period		$	56,217			$	69,746
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Right-of-use assets obtained in exchange for operating lease liabilities		$	147			$	2,234

CONTACT:

Scott Davidson
Senior Vice President and Chief Financial Officer
Natural Health Trends Corp.
Tel (Hong Kong): +852-3107-0800
Tel (U.S.): 310-541-0888
investor.relations@nhtglobal.com